| Name | Title | Contact Details |
|---|
Interlude Limited is a Dartmouth, NS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Accelerating progress and time to market of biopharmaceuticals with our integrated CDMO and Testing Service Platform. Global HQ in Philadelphia, PA.
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
GuideWell Source is a leading administrative services company providing full-service, end-to-end business services for health plans and government sponsored health care programs.
Living Well Health Solutions is a Charlotte, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.